Jo Huiqing Zhou, theme Reconstructive and regenerative medicine and Simon van Heeringen, theme Infectious diseases and global health, received an NWO ALW grant for a project entitled: A matter of identity: master regulator p63-orchestrated transcription factor circuitry in the epithelial cell fate determination of normal development and disease.
Jo Huiqing Zhou
Simon van Heeringen
In regenerative medicine, organ repair or replacement using cells and tissues generated from patients’ own material is promising and shows rapid development. Understanding how cell identity is determined is instrumental to effectively drive this progress. Cell fate determination is a complex process that is essential for normal development, and disruption of this process gives rise to developmental diseases. The aim of this ALW-Open project is to identify deterministic transcription factors for two epithelial cell types, epidermal and corneal limbal cells. As the transcription factor p63 is a key regulator in epithelial cell determination, we will identify p63-centered transcription factor networks that are important for defining specific epidermal and limbal fates and for related diseases, using multi-omics (transcriptomics, epigenomics and proteomic) analyses in combination with computational modeling. The identified key factors can be applied for controlled cell type conversions, especially towards corneal limbal cells that are difficult to obtain, thus providing tools for regenerative medicine. This project will also shed light on mechanisms of disorders related to epithelial development.
Jo Huiqing Zhou
Simon van Heeringen
Related news items

RIMLS awards call for nominations
19 October 2021 RIMLS awards several prizes to stimulate and honor our (young) researchers. Upcoming awards are Supervisor of the Year, Best Master Thesis, Best Publication, Best Image and more. Send your nominations now before 24 November 2021. read more
Miniaturized microfluidic platform for automated epigenetic profiling
6 May 2021 Together with Fluidigm, a US-based company focusing on microfluidics, the team of Hendrik Marks publishes in Genome Research the development of a powerful plug and play ChIP-seq platform for minute amount of cells, such as embryonic specimens or small biopsies. read more

RIMLS online award ceremony proudly presenting the winners
13 January 2021In this special webinar of the RIMLS New Year Celebration, scientific director René Bindels reviewed 2020 and looked forward to 2021. But more importantly a number of researchers received prizes in the traditional RIMLS awards ceremony.
read more
Polyisocyanide Hydrogels as a Tunable Platform for Mammary Gland Organoid Formation
28 October 2020 A multidisciplinary team of RIMLS and Radboud University researchers published in Advanced Science that Polyisocyanide Hydrogels as a Tunable Platform for Mammary Gland Organoid Formation. read more
RIMLS PhD retreat registration is open
23 January 2020 Yearly, RIMLS PhD candidates gather for the two-day PhD Retreat. Apart from the science, this event is highly valued for the opportunity to meet and get to know fellow PhD candidates during the social activities. Early bird registration and abstract submission deadline: 4 March 2020. read more